预测性高血糖与低血糖最小化:1型糖尿病夜间血糖控制安全性、可行性与有效性的家庭内评估
本研究在30例15-45岁1型糖尿病患者中开展42晚随机盲法交叉试验,比较预测性高血糖与低血糖最小化(PHHM)系统与单独预测性低血糖胰岛素暂停(PLGS)的夜间血糖控制效果。PHHM夜间目标范围(70-180 mg/dL)时间占比为78±10%,高于PLGS夜间的71±10%(P<0.001);晨间血糖从PLGS夜间的163±23 mg/dL改善至PHHM夜间的142±18 mg/dL(P<0.001)。传感器测定的低血糖结局在两种夜间相似,无严重低血糖、糖尿病酮症酸中毒或研究/设备相关不良事件。
要点
- PHHM较PLGS提高夜间目标血糖范围时间占比(78±10% vs 71±10%,P<0.001)。
- PHHM较PLGS改善晨间血糖(142±18 mg/dL vs 163±23 mg/dL,P<0.001)。
- 两种夜间传感器低血糖结局相似,无严重低血糖或设备相关不良事件。
核心结论
- 在现有PLGS系统上增加预测性高血糖最小化组件在夜间血糖控制中显示安全、可行且有效。
研究设计与样本
- 42晚试验纳入30例15-45岁1型糖尿病患者,每晚随机分配至PHHM或PLGS且对分组盲法。
- PHHM与PLGS夜间均因预测低血糖暂停胰岛素泵,仅PHHM夜间对预测高血糖给予校正大剂量。
- 主要结局为夜间传感器血糖70-180 mg/dL时间占比。
主要发现
- PHHM夜间目标范围(70-180 mg/dL)时间占比为78±10%,PLGS夜间为71±10%(P<0.001)。
- 晨间血糖浓度从PLGS夜间的163±23 mg/dL改善至PHHM夜间的142±18 mg/dL(P<0.001)。
- 传感器测定的各项低血糖结局在PLGS与PHHM夜间相似。
- 所有参与者完成42晚,无严重低血糖、糖尿病酮症酸中毒或其他研究或设备相关不良事件。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to determine the safety, feasibility, and efficacy of a predictive hyperglycemia and hypoglycemia minimization (PHHM) system compared with predictive low-glucose insulin suspension (PLGS) alone in overnight glucose control. RESEARCH DESIGN AND METHODS: A 42-night trial was conducted in 30 individuals with type 1 diabetes in the age range 15-45 years. Participants were randomly assigned each night to either PHHM or PLGS and were blinded to the assignment. The system suspended the insulin pump on both the PHHM and PLGS nights for predicted hypoglycemia but delivered correction boluses for predicted hyperglycemia on PHHM nights only. The primary outcome was the percentage of time spent in a sensor glucose range of 70-180 mg/dL during the overnight period. RESULTS: The addition of automated insulin delivery with PHHM increased the time spent in the target range (70-180 mg/dL) from 71 ± 10% during PLGS nights to 78 ± 10% during PHHM nights (P < 0.001). The average morning blood glucose concentration improved from 163 ± 23 mg/dL after PLGS nights to 142 ± 18 mg/dL after PHHM nights (P < 0.001). Various sensor-measured hypoglycemic outcomes were similar on PLGS and PHHM nights. All participants completed 42 nights with no episodes of severe hypoglycemia, diabetic ketoacidosis, or other study- or device-related adverse events. CONCLUSIONS: The addition of a predictive hyperglycemia minimization component to our existing PLGS system was shown to be safe, feasible, and effective in overnight glucose control.
引用
- Spaic T, Driscoll M, Raghinaru D, et al. Predictive Hyperglycemia and Hypoglycemia Minimization: In-Home Evaluation of Safety, Feasibility, and Efficacy in Overnight Glucose Control in Type 1 Diabetes. Diabetes Care. 2017. PMID: 28100606. doi:10.2337/dc16-1794
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。